Patent · US Active

Platelet aggregation assays using a CD40L-binding agent

US8409810B2 · kind B2 · utility

0Cited by
3References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 2006
Grant dateApr 2, 2013
Priority date
Expiry dateDec 5, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/86
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides methods of determining platelet aggregation, methods of determining susceptibility to clotting upon administration of a CD40L-binding moiety, and kits related thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.